Lee Ainslie's AMGN Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 2,562 shares of Amgen Inc. (AMGN) worth $1.08 M, representing 0.01% of the portfolio. First purchased in 2015-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in AMGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 6,420 shares. Largest reduction occurred in Q3 2017, reducing 10,200 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +2,562 | New Buy | 2,562 | $421.51 |
| Q4 2023 | -1,882 | Sold Out | 0 | $0.00 |
| Q3 2023 | +1,882 | New Buy | 1,882 | $268.76 |
| Q3 2021 | -1,670 | Sold Out | 0 | $0.00 |
| Q2 2021 | +1,561 | Add 1432.11% | 1,670 | $243.71 |
| Q1 2021 | +109 | New Buy | 109 | $247.71 |
| Q4 2019 | -4,862 | Sold Out | 0 | $0.00 |
| Q3 2019 | +4,862 | New Buy | 4,862 | $193.54 |
| Q3 2017 | -10,200 | Sold Out | 0 | $0.00 |
| Q2 2017 | +6,420 | Add 169.84% | 10,200 | $172.25 |
| Q1 2017 | -790 | Reduce 17.29% | 3,780 | $164.02 |
| Q4 2016 | +940 | Add 25.90% | 4,570 | $146.17 |
| Q3 2016 | -310 | Reduce 7.87% | 3,630 | $166.94 |
| Q2 2016 | +480 | Add 13.87% | 3,940 | $152.03 |
| Q1 2016 | +1,780 | Add 105.95% | 3,460 | $150.00 |
| Q2 2015 | +110 | Add 7.01% | 1,680 | $153.57 |
| Q1 2015 | +1,570 | New Buy | 1,570 | $159.87 |
Lee Ainslie's Amgen Investment FAQs
Lee Ainslie first purchased Amgen Inc. (AMGN) in Q1 2015, acquiring 1,570 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Amgen Inc. (AMGN) for 19 quarters since Q1 2015.
Lee Ainslie's largest addition to Amgen Inc. (AMGN) was in Q2 2017, adding 10,200 shares worth $1.76 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 2,562 shares of Amgen Inc. (AMGN), valued at approximately $1.08 M.
As of the Q3 2026 filing, Amgen Inc. (AMGN) represents approximately 0.01% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Amgen Inc. (AMGN) was 10,200 shares, as reported at the end of Q2 2017.